Cargando…
Drug Repurposing of Metabolic Agents in Malignant Glioma
Gliomas are highly invasive brain tumors with short patient survival. One major pathogenic factor is aberrant tumor metabolism, which may be targeted with different specific and unspecific agents. Drug repurposing is of increasing interest in glioma research. Drugs interfering with the patient’s met...
Autores principales: | Seliger, Corinna, Hau, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164672/ https://www.ncbi.nlm.nih.gov/pubmed/30223473 http://dx.doi.org/10.3390/ijms19092768 |
Ejemplares similares
-
Antimicrobial drug use and the risk of glioma: A case–control study
por: Haedenkamp, Tareq M., et al.
Publicado: (2022) -
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
por: Gerthofer, Valeria, et al.
Publicado: (2018) -
DIPG-13. TARGETING HYPOXIA AND MITOCHONDRIA WITH REPURPOSED METABOLIC DRUGS AS AN APPROACH TO RADIOSENSITIZATION FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)
por: Shen, Han, et al.
Publicado: (2020) -
Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019) -
Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)